Cullen/Frost Bankers’s Pediatrix Medical MD Stock Holding History

Cullen/Frost Bankers’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.1K	Buy	1,347 +144	+12%	+$3.28K	﹤0.01%	960
2026 Q1	$25.7K	Buy	1,203 +65	+6%	+$1.35K	﹤0.01%	929
2025 Q4	$24.4K	Buy	1,138 +219	+24%	+$4.49K	﹤0.01%	956
2025 Q3	$15.4K	Buy	+919	New	+$13.8K	﹤0.01%	996
2022 Q2	–	Sell	-13	Closed	–	–	1144
2022 Q1	$0	Hold	13	–	–	﹤0.01%	1221
2021 Q4	$0	Sell	13 -1,654	-99%	-$44.3K	﹤0.01%	1268
2021 Q3	$47K	Hold	1,667	–	–	﹤0.01%	779
2021 Q2	$50K	Buy	+1,667	New	+$49.2K	﹤0.01%	780
2019 Q2	–	Sell	-15	Closed	–	–	1078
2019 Q1	$0	Buy	+15	New	+$503	﹤0.01%	952

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Cullen/Frost Bankers's MD Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Pediatrix Medical (MD) stake by 12% in Q2 2026, buying an estimated $3.28K and bringing the position to 1,347 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

Cullen/Frost Bankers first reported a position in MD in Q1 2019 and has held it in 9 quarters since. The position peaked at $50K in Q2 2021. 129 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Cullen/Frost Bankers held 1,347 shares of Pediatrix Medical worth $34.1K as of Q2 2026.
Cullen/Frost Bankers bought 144 Pediatrix Medical shares in Q2 2026, an estimated $3.28K.
Pediatrix Medical made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #960 holding.
Cullen/Frost Bankers first reported a position in Pediatrix Medical in Q1 2019 and has held it in 9 quarters since.
Cullen/Frost Bankers's Pediatrix Medical position peaked at $50K in Q2 2021.
129 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.